Current portfolio

Lima

A leading orthopaedic implant manufacturer based in Italy and a pioneer in additive manufacturing with its proprietary Trabecular TitaniumTM technology

Lima is solely focused on its medical activities, respectively orthopaedic implants, and its portfolio covers the vast majority of the orthopaedic product spectrum including its highly regarded ‘SMR’ shoulder, ‘Physica’ knee and revision (i.e. replacement implant) offerings.

  • Sector
    Healthcare
  • Country
    Italy
  • Responsible Advisor
    Michael Bauer
  • Fund
    EQT VII
  • Entry
    2016
  • Web
3

Private Capital

Lima

  • Societal Contribution

  • 3Good health and well-being
Logo

Lima was founded in 1945 by the Italian Lualdi family as a manufacturer of surgical instruments and throughout its lifetime has ventured into many different fields including aeronautics and Formula 1 reflecting the Company’s engineering spirit. Since almost 20 years, Lima is solely focused on its medical activities, respectively orthopaedic implants, and its portfolio covers the vast majority of the orthopaedic product spectrum including its highly regarded ‘SMR’ shoulder, ‘Physica’ knee and revision (i.e. replacement implant) offerings.

Lima has a strong R&D and innovation heritage reflected in its industry-leading position in additive manufacturing as the largest medical user of Electronic Beam Machinery for 3D-printing thanks to its Trabecular TitaniumTM technology as well as its best in-class production facilities in Italy and San Marino.

Today, Lima is a global player in the orthopaedic space present in more than 40 countries.

To Lima

Market trends and drivers
The global orthopaedic market is expected to grow by approximately 5% per annum going forward with higher growth in Lima’s niche segments shoulder and revision products. The market benefits from favourable underlying fundamentals such as general population growth, ageing society and active lifestyles resulting in healthy and resilient growth dynamics.

Investment potential
EQT’s value creation plan for Lima is focused on accelerating growth even further, specifically in the US as the largest orthopaedic market globally, fully leveraging Lima’s global platform to selectively consolidate as well as further penetration of regional markets with its well diversified product portfolio. The Board of Directors consists of experienced industry veterans who will support management and staff in the further development of Lima.

Board of directors

  • Chairperson
    Michel Orsinger
  • Board member
    Massimo Rossi
  • Board member
    Michael Bauer
  • Board member
    Doug Kohrs
  • Board member
    Eric Lohrer
  • Board member
    Rodrigo Bianchi
  • Board member
    Petra Rumpf

Management

  • CEO
    Luigi Ferrari
  • CFO
    Michele Marin